Calcalist: Israel-based firm that develops targeted therapies for cancer is planning an initial public offering of shares at company valuation of $400 million
Calcalist: The Israel-based firm is seeking to raise some $100 million at a company valuation of $400 million to $500 million, two people familiar with the matter say
Calcalist: The Israeli firm that develops headsets to treat brain disorders by using magnetic stimulation is now dually listed in Tel Aviv and on the Nasdaq
Recent comments